Raymond James & Associates’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.21M | Buy |
25,713
+4,065
| +19% | +$508K | ﹤0.01% | 1925 |
|
|
2024
Q2 | $3.42M | Buy |
21,648
+8,992
| +71% | +$1.42M | ﹤0.01% | 1839 |
|
|
2024
Q1 | $1.64M | Buy |
12,656
+2,857
| +29% | +$370K | ﹤0.01% | 2284 |
|
|
2023
Q4 | $945K | Sell |
9,799
-539
| -5% | -$52K | ﹤0.01% | 2538 |
|
|
2023
Q3 | $1.25M | Sell |
10,338
-2,817
| -21% | -$341K | ﹤0.01% | 2303 |
|
|
2023
Q2 | $1.51M | Sell |
13,155
-182
| -1% | -$20.8K | ﹤0.01% | 2224 |
|
|
2023
Q1 | $1.84M | Buy |
13,337
+1,659
| +14% | +$229K | ﹤0.01% | 2075 |
|
|
2022
Q4 | $1.51M | Sell |
11,678
-2,466
| -17% | -$320K | ﹤0.01% | 2175 |
|
|
2022
Q3 | $1.56M | Sell |
14,144
-148
| -1% | -$16.4K | ﹤0.01% | 2119 |
|
|
2022
Q2 | $1.07M | Buy |
14,292
+154
| +1% | +$11.5K | ﹤0.01% | 2382 |
|
|
2022
Q1 | $1.1M | Buy |
14,138
+522
| +4% | +$40.8K | ﹤0.01% | 2518 |
|
|
2021
Q4 | $1.23M | Buy |
13,616
+5,675
| +71% | +$511K | ﹤0.01% | 2481 |
|
|
2021
Q3 | $734K | Sell |
7,941
-132
| -2% | -$12.2K | ﹤0.01% | 2774 |
|
|
2021
Q2 | $628K | Sell |
8,073
-383
| -5% | -$29.8K | ﹤0.01% | 2914 |
|
|
2021
Q1 | $630K | Sell |
8,456
-27,526
| -76% | -$2.05M | ﹤0.01% | 2837 |
|
|
2020
Q4 | $6.14M | Buy |
35,982
+2,538
| +8% | +$433K | 0.01% | 1223 |
|
|
2020
Q3 | $4.7M | Buy |
33,444
+10,176
| +44% | +$1.43M | 0.01% | 1266 |
|
|
2020
Q2 | $3.73M | Buy |
23,268
+1,550
| +7% | +$249K | 0.01% | 1365 |
|
|
2020
Q1 | $2.12M | Sell |
21,718
-4,135
| -16% | -$404K | ﹤0.01% | 1530 |
|
|
2019
Q4 | $3.34M | Buy |
25,853
+2,470
| +11% | +$319K | ﹤0.01% | 1520 |
|
|
2019
Q3 | $1.76M | Buy |
23,383
+5,150
| +28% | +$388K | ﹤0.01% | 1852 |
|
|
2019
Q2 | $2.77M | Buy |
18,233
+628
| +4% | +$95.4K | ﹤0.01% | 1597 |
|
|
2019
Q1 | $2.1M | Buy |
17,605
+1,667
| +10% | +$199K | ﹤0.01% | 1737 |
|
|
2018
Q4 | $1.74M | Sell |
15,938
-7,296
| -31% | -$796K | ﹤0.01% | 1747 |
|
|
2018
Q3 | $3.75M | Buy |
23,234
+7,258
| +45% | +$1.17M | 0.01% | 1400 |
|
|
2018
Q2 | $2.11M | Sell |
15,976
-8,334
| -34% | -$1.1M | ﹤0.01% | 1721 |
|
|
2018
Q1 | $1.8M | Sell |
24,310
-43
| -0.2% | -$3.19K | ﹤0.01% | 1766 |
|
|
2017
Q4 | $1.36M | Sell |
24,353
-528
| -2% | -$29.4K | ﹤0.01% | 1952 |
|
|
2017
Q3 | $1.13M | Buy |
24,881
+14,341
| +136% | +$651K | ﹤0.01% | 2023 |
|
|
2017
Q2 | $355K | Buy |
10,540
+3,222
| +44% | +$109K | ﹤0.01% | 2608 |
|
|
2017
Q1 | $217K | Sell |
7,318
-2,861
| -28% | -$84.8K | ﹤0.01% | 2868 |
|
|
2016
Q4 | $279K | Sell |
10,179
-11,244
| -52% | -$308K | ﹤0.01% | 2650 |
|
|
2016
Q3 | $1.32M | Buy |
21,423
+6,272
| +41% | +$385K | ﹤0.01% | 1709 |
|
|
2016
Q2 | $289K | Buy |
15,151
+2,300
| +18% | +$43.9K | ﹤0.01% | 2424 |
|
|
2016
Q1 | $251K | Buy |
12,851
+765
| +6% | +$14.9K | ﹤0.01% | 2442 |
|
|
2015
Q4 | $466K | Buy |
12,086
+550
| +5% | +$21.2K | ﹤0.01% | 2019 |
|
|
2015
Q3 | $370K | Buy |
11,536
+1,004
| +10% | +$32.2K | ﹤0.01% | 2056 |
|
|
2015
Q2 | $320K | Buy |
+10,532
| New | +$320K | ﹤0.01% | 2249 |
|
|
2015
Q1 | – | Sell |
-16,697
| Closed | -$242K | – | 2388 |
|
|
2014
Q4 | $242K | Buy |
16,697
+3,275
| +24% | +$47.5K | ﹤0.01% | 2170 |
|
|
2014
Q3 | $283K | Hold |
13,422
| – | – | ﹤0.01% | 2049 |
|
|
2014
Q2 | $400K | Buy |
13,422
+3,394
| +34% | +$101K | ﹤0.01% | 1935 |
|
|
2014
Q1 | $241K | Buy |
+10,028
| New | +$241K | ﹤0.01% | 2024 |
|
|
2013
Q4 | – | Sell |
-33,822
| Closed | -$1.6M | – | 2014 |
|
|
2013
Q3 | $1.6M | Sell |
33,822
-26,139
| -44% | -$1.23M | 0.01% | 990 |
|
|
2013
Q2 | $2.28M | Buy |
+59,961
| New | +$2.28M | 0.02% | 744 |
|